ZyVersa Therapeutics Forms New Scientific Advisory Board to Support Development of Inflammasome ASC Inhibitor IC 100 for Obesity with Metabolic Complications

2 weeks ago

ZyVersa Therapeutics forms new obesity, metabolic and inflammatory disease Scientific Advisory Board.

Ticker	Sentiment	Impact
ZVSA	Neutral	14 %